ZJM stock holds near its latest trade. Zymeworks data still drives the setup
Published on 08/31/2026 at 19:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Zymeworks Inc. (CA98959U1084) stock is trading with a fresh quote backdrop and a current operating snapshot that centers on second-quarter 2026 figures. TradingView shows ZYME at $28.31 in pre-market trading with a prior $28.27 snapshot and a 2.55% drop, while the same page also flags a 52-week range that investors can read against the latest move.
Quarterly numbers
The most recent operating data visible in the search set is for Q2 2026, when enterprise value to revenue forward stood at 4.06, after 4.35 in Q1 2026. That change matters because the page also shows 5.69 for fiscal 2025, which gives investors a concrete year-over-year reference for how the valuation profile has shifted.
For a second operating anchor, the same data set shows the forward enterprise value to EBIT metric at 4.06 in Q2 2026, compared with 4.35 in Q1 2026 and 5.23 in Q4 2025. The move from 5.23 to 4.06 is a quantified comparison that points to a lower multiple than in the prior quarter.
What the market is pricing
The stock's latest visible quote sits alongside a market-cap style context that keeps the discussion tied to current trading rather than old report history. For investors, that combination of a live quote and Q2 2026 operating multiples is the clearest read available from the session.
The company context remains centered on Zymeworks' listed equity, and the ISIN in the input matches the issuer identity used here. That makes the market data and the quarterly ratio series the most relevant live signals in the current set.
Zymeworks product context
Zymeworks is a biotechnology company, so the business case is still driven by its drug-development pipeline and the way investors value that pipeline against reported operating metrics. The current quote and the Q2 2026 ratio data frame that story without relying on older annual figures.
Latest trade view
As of August 31, 2026, the latest visible price in the search set is $28.31, with a prior $28.27 snapshot and a 2.55% move on the TradingView page. That keeps ZJM in a tight market-data frame while the Q2 2026 metrics remain the freshest operating comparison available here.
Fact box
Company: Zymeworks Inc.
ISIN: CA98959U1084
Ticker: ZYME
Exchange: NASDAQ
Price (as of August 31, 2026): $28.31 USD
